EVERETT, Wash.--(BUSINESS WIRE)--SNBL USA, the experts in nonhuman primate (NHP) toxicology, is pleased to announce the addition of three experienced business development professionals to its team. Terry Ladd, MA, MBA joins SNBL USA as a Senior Director of Business Development and will be responsible for the business development operations for Eastern Canada and the New England region of the United States. With over 20 years of business development experience in the preclinical field, Mr. Ladd has held senior management positions in business development and marketing and has previously worked with Calvert Laboratories, Inc., MDS Pharma Services, Inc. and SkeleTech, Inc., among others.
